Principle Investigator:
Zhonglin Hao, MD, PhD
“SNX-5422-CLN1-006; A Phase 1, Open-label, Dose-escalation Study of SNX 5422 plus Carboplatin and Paclitaxel in Subjects with Selected Solid Tumors” Sponsor: Esanex Inc.
Principle Investigator:
Zhonglin Hao, MD, PhD
“SNX-5422-CLN1-006; A Phase 1, Open-label, Dose-escalation Study of SNX 5422 plus Carboplatin and Paclitaxel in Subjects with Selected Solid Tumors” Sponsor: Esanex Inc.
Zhonglin Hao, MD, PhD, Co-leader, Thoracic Oncology Program, now serves on the Editorial Board of Advances in Modern Oncology Research.